Works by Mengke Niu

Results: 28

Numerical investigation of conjugated heat transfer mechanisms of supercritical hydrogen-helium in PCHE channels.

Published in:

Numerical Heat Transfer: Part A -- Applications, 2025, v. 86, n. 12, p. 4158, doi. 10.1080/10407782.2024.2310877

By:

Wang, Wei;
Ding, Liang;
Niu, Mengke;
Li, Bingxi;
Shuai, Yong;
Sunden, Bengt

Publication type:

Article

Increased expression of ECT2 predicts the poor prognosis of breast cancer patients.

Published in:

Experimental Hematology & Oncology, 2022, v. 11, n. 1, p. 1, doi. 10.1186/s40164-022-00361-3

By:

Yi, Ming;
Zhang, Di;
Song, Bin;
Zhao, Bin;
Niu, Mengke;
Wu, Yuze;
Dai, Zhijun;
Wu, Kongming

Publication type:

Article

Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC.

Published in:

Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00211-8

By:

Niu, Mengke;
Yi, Ming;
Li, Ning;
Luo, Suxia;
Wu, Kongming

Publication type:

Article

CD44 as a tumor biomarker and therapeutic target.

Published in:

Experimental Hematology & Oncology, 2020, v. 9, n. 1, p. 1, doi. 10.1186/s40164-020-00192-0

By:

Xu, Hanxiao;
Niu, Mengke;
Yuan, Xun;
Wu, Kongming;
Liu, Aiguo

Publication type:

Article

Synergistic efficacy of simultaneous anti-TGF-β/VEGF bispecific antibody and PD-1 blockade in cancer therapy.

Published in:

Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01487-5

By:

Niu, Mengke;
Yi, Ming;
Wu, Yuze;
Lyu, Lijuan;
He, Qing;
Yang, Rui;
Zeng, Liang;
Shi, Jian;
Zhang, Jing;
Zhou, Pengfei;
Zhang, Tingting;
Mei, Qi;
Chu, Qian;
Wu, Kongming

Publication type:

Article

Combination of oral STING agonist MSA-2 and anti-TGF-β/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors.

Published in:

Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01363-8

By:

Yi, Ming;
Niu, Mengke;
Wu, Yuze;
Ge, Hong;
Jiao, Dechao;
Zhu, Shuangli;
Zhang, Jing;
Yan, Yongxiang;
Zhou, Pengfei;
Chu, Qian;
Wu, Kongming

Publication type:

Article

S100A8/A9 as a risk factor for breast cancer negatively regulated by DACH1.

Published in:

Biomarker Research, 2023, v. 11, n. 1, p. 1, doi. 10.1186/s40364-023-00548-8

By:

Zhang, Xiaojun;
Niu, Mengke;
Li, Tianye;
Wu, Yuze;
Gao, Jinnan;
Yi, Ming;
Wu, Kongming

Publication type:

Article

Biological Characteristics and Clinical Significance of Soluble PD-1/PD-L1 and Exosomal PD-L1 in Cancer.

Published in:

Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.827921

By:

Niu, Mengke;
Liu, Yiming;
Yi, Ming;
Jiao, Dechao;
Wu, Kongming

Publication type:

Article

Targeting cytokine and chemokine signaling pathways for cancer therapy.

Published in:

Signal Transduction & Targeted Therapy, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41392-024-01868-3

By:

Yi, Ming;
Li, Tianye;
Niu, Mengke;
Zhang, Haoxiang;
Wu, Yuze;
Wu, Kongming;
Dai, Zhijun

Publication type:

Article

Effects of Mn Content on Microstructure and Mechanical Properties of Co-Free Medium Entropy Alloys in the Cr-Fe-Mn-Ni System.

Published in:

Materials Transactions, 2024, v. 65, n. 12, p. 1501, doi. 10.2320/matertrans.MT-MA2024012

By:

Mengke Niu;
Naoyuki Hashimoto;
Hiroshi Oka;
Haotian Sun

Publication type:

Article

Investigation on Flow Maldistribution and Thermo-Hydraulic Performance of PCHEs with Spoiler Perforated Boards.

Published in:

Energies (19961073), 2022, v. 15, n. 18, p. 6518, doi. 10.3390/en15186518

By:

Wang, Wei;
Niu, Mengke;
Tan, Yufei;
Li, Bingxi;
Shuai, Yong

Publication type:

Article

Efficacy of Chemotherapy versus Transcatheter Arterial Chemoembolization in Patients with Advanced Primary Hepatic Neuroendocrine Carcinoma and an Analysis of the Prognostic Factors: A Retrospective Study.

Published in:

Cancer Management & Research, 2021, v. 13, p. 9085, doi. 10.2147/CMAR.S343572

By:

Li, Shuyi;
Niu, Mengke;
Deng, Wenying;
Li, Ning;
Wei, Chen;
Zhang, Chi;
Luo, Suxia

Publication type:

Article

Combine and conquer: manganese synergizing anti-TGF-β/PD-L1 bispecific antibody YM101 to overcome immunotherapy resistance in non-inflamed cancers.

Published in:

Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01155-6

By:

Yi, Ming;
Niu, Mengke;
Zhang, Jing;
Li, Shiyu;
Zhu, Shuangli;
Yan, Yongxiang;
Li, Ning;
Zhou, Pengfei;
Chu, Qian;
Wu, Kongming

Publication type:

Article

The construction, expression, and enhanced anti-tumor activity of YM101: a bispecific antibody simultaneously targeting TGF-β and PD-L1.

Published in:

Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01045-x

By:

Yi, Ming;
Zhang, Jing;
Li, Anping;
Niu, Mengke;
Yan, Yongxiang;
Jiao, Ying;
Luo, Suxia;
Zhou, Pengfei;
Wu, Kongming

Publication type:

Article

Regulation of PD-L1 expression in the tumor microenvironment.

Published in:

Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-020-01027-5

By:

Yi, Ming;
Niu, Mengke;
Xu, Linping;
Luo, Suxia;
Wu, Kongming

Publication type:

Article

Epidemiological trends of women's cancers from 1990 to 2019 at the global, regional, and national levels: a population-based study.

Published in:

Biomarker Research, 2021, v. 9, n. 1, p. 1, doi. 10.1186/s40364-021-00310-y

By:

Yi, Ming;
Li, Tianye;
Niu, Mengke;
Luo, Suxia;
Chu, Qian;
Wu, Kongming

Publication type:

Article

Blockade of CCR5<sup>+</sup> T Cell Accumulation in the Tumor Microenvironment Optimizes Anti‐TGF‐β/PD‐L1 Bispecific Antibody.

Published in:

Advanced Science, 2024, v. 11, n. 43, p. 1, doi. 10.1002/advs.202408598

By:

Yi, Ming;
Li, Tianye;
Niu, Mengke;
Wu, Yuze;
Zhao, Bin;
Shen, Zhuoyang;
Hu, Shengtao;
Zhang, Chaomei;
Zhang, Xiaojun;
Zhang, Jing;
Yan, Yongxiang;
Zhou, Pengfei;
Chu, Qian;
Dai, Zhijun;
Wu, Kongming

Publication type:

Article

Beyond success: unveiling the hidden potential of radiotherapy and immunotherapy in solid tumors.

Published in:

Cancer Communications, 2024, v. 44, n. 7, p. 739, doi. 10.1002/cac2.12576

By:

Wu, Yuze;
Yi, Ming;
Niu, Mengke;
Zhou, Binghan;
Mei, Qi;
Wu, Kongming

Publication type:

Article

STING agonist inflames the cervical cancer immune microenvironment and overcomes anti-PD-1 therapy resistance.

Published in:

Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1342647

By:

Tianye Li;
Weijiang Zhang;
Mengke Niu;
Yuze Wu;
Xinyue Deng;
Jianwei Zhou

Publication type:

Article

CAR-NK cells for cancer immunotherapy: recent advances and future directions.

Published in:

Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1361194

By:

Tianye Li;
Mengke Niu;
Weijiang Zhang;
Shuang Qin;
Jianwei Zhou;
Ming Yi

Publication type:

Article

Bispecific antibody targeting TGF-β and PD-L1 for synergistic cancer immunotherapy.

Published in:

Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1196970

By:

Tianye Li;
Xinrun Wang;
Mengke Niu;
Mingli Wang;
Jianwei Zhou;
Kongming Wu;
Ming Yi

Publication type:

Article

The enhanced antitumor activity of bispecific antibody targeting PD-1/PD-L1 signaling.

Published in:

Cell Communication & Signaling, 2024, v. 22, n. 1, p. N.PAG, doi. 10.1186/s12964-024-01562-5

By:

Li, Tianye;
Niu, Mengke;
Zhou, Jianwei;
Wu, Kongming;
Yi, Ming

Publication type:

Article

The enhanced antitumor activity of bispecific antibody targeting PD-1/PD-L1 signaling.

Published in:

Cell Communication & Signaling, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12964-024-01562-5

By:

Li, Tianye;
Niu, Mengke;
Zhou, Jianwei;
Wu, Kongming;
Yi, Ming

Publication type:

Article

Advances of Targeted Therapy for Hepatocellular Carcinoma.

Published in:

Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.719896

By:

Niu, Mengke;
Yi, Ming;
Li, Ning;
Wu, Kongju;
Wu, Kongming

Publication type:

Article

Exploiting innate immunity for cancer immunotherapy.

Published in:

Molecular Cancer, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12943-023-01885-w

By:

Yi, Ming;
Li, Tianye;
Niu, Mengke;
Mei, Qi;
Zhao, Bin;
Chu, Qian;
Dai, Zhijun;
Wu, Kongming

Publication type:

Article

Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy.

Published in:

2022

By:

Wu, Yuze;
Yi, Ming;
Niu, Mengke;
Mei, Qi;
Wu, Kongming

Publication type:

Literature Review

Combination strategies with PD-1/PD-L1 blockade: current advances and future directions.

Published in:

2022

By:

Yi, Ming;
Zheng, Xiaoli;
Niu, Mengke;
Zhu, Shuangli;
Ge, Hong;
Wu, Kongming

Publication type:

Literature Review

Anti-TGF-β/PD-L1 bispecific antibody synergizes with radiotherapy to enhance antitumor immunity and mitigate radiation-induced pulmonary fibrosis.

Published in:

Journal of Hematology & Oncology, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13045-025-01678-2

By:

Wu, Yuze;
Yan, Yuheng;
Guo, Yarong;
Niu, Mengke;
Zhou, Binghan;
Zhang, Jing;
Zhou, Pengfei;
Chu, Qian;
Mei, Qi;
Yi, Ming;
Wu, Kongming

Publication type:

Article